Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,431
Sort by:
Analyzing the Global Diabetes Market 2016
US$ 1,000.00
... for diabetes are analyzed in this section. We also look at diabetes epidemiology. Moving to the next section, we analyze the global diabetes market through a market overview and an analysis of the market by diabetes ...
September 2016
195 pages
US Breast Cancer Drug Market Outlook 2022
US$ 1,800.00
... Breast Cancer Drug Market Outlook 2022” Report Highlights: US Breast Cancer Tendencies US Breast Cancer Drug Market Outline US Breast Cancer Drug Market Dynamics Breast Cancer Risk Undercurrents US Breast Cancer Marketed Drugs Clinical Insight by Company & Patent Analysis US Breast Cancer Marketed ...
September 2016
130 pages
Exosome Diagnostic and Therapeutic Market by Application (Diagnostic and Therapeutic), Product (Instrument, Reagent and Software) and End-User (Cancer Institute, Hospital, Diagnostic Center, and Others) - Global Opportunity Analysis and Industry Forecasts, 2014-2022
US$ 4,432.00
... outlook of the market. Key market segments The world exosome diagnostic and therapeutic market is segmented into application, product, end user, and geography. MARKET BY APPLICATION Diagnostic Therapeutic MARKET BY PRODUCT Instrument ...
September 2016
115 pages
Ulcerative Colitis: KOL Insight
US$ 7,900.00
... UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs ... advantage. Update Bulletins include expert insight and analysis based on FirstWord analyst re-engagement with the KOLs after major events such as product ...
August 2016
Hepatitis C: KOL Insight
US$ 7,900.00
... options? Since the launch of Sovaldi (sofosbuvir; Gilead) in 2013, the hepatitis C (HCV) landscape has developed at a rapid pace. The focus has ... report reveals candid insights about the HCV landscape from 12 KOLs in North America and Europe. You’ll learn which treatments KOLs have confidence ... advantage. Update Bulletins include expert insight and analysis based on FirstWord analyst re-engagement with the KOLs after major events such as product ...
August 2016
Cancer/Tumor Profiling - Global Market Outlook (2016-2022)
US$ 4,150.00
... MRC, the Global Cancer/Tumor Profiling market is expected to grow from $23.04 billion in 2015 to reach $78.69 billion by 2022 with a CAGR of 19.2%. Increasing cases of cancer and the need ... cancer profiling industry leaders. Asia Pacific is expected to witness huge growth due to raising incidence of cancer in this region. Some of the key players in global Cancer/Tumor profiling market ...
August 2016
147 pages
Industrial Control And Factory Automation - Global Market Outlook (2016-2022)
US$ 4,150.00
According to Stratistics MRC, the Global Industrial Control and Factory Automation market is accounted for $138.56 billion in 2015 and is expected to reach $ ... India. Factory automation is increasing in China, due to the large number of automotive manufacturing plants. Some of the key players of the Industrial Control and Factory Automation market include ...
August 2016
134 pages
Industrial Gases - Global Market Outlook (2016-2022)
US$ 4,150.00
... Global Industrial Gases market is accounted for $46.23 billion in 2015 and is expected to reach $79.75 billion by 2022 growing at a CAGR of 8.1%. Wide range applications of industrial gases are carving opportunities in market ... factors contributing to regional growth. Some of the key players of the Industrial Gases market include Air Gas Inc., Air Products and Chemicals Inc ...
August 2016
121 pages
Market Access Impact: Non-Small Cell Lung Cancer (EU5) 2016
US$ 4,995.00
... 3 rival brands managed small barrier-related gains? Which barriers have the biggest impact on market share? Find out in Market Access Impact: NSCLC. Request sample pages ... ) Exploring Important Market Access Issues Market Access Impact: NSCLC explores key issues affecting NSCLC drug manufacturers. You’ll learn: How barriers affect market access: What brands ...
August 2016
Market Access Impact: Non-Small Cell Lung Cancer (US) 2016
US$ 4,995.00
... barriers related to market access affect slightly more prescriptions than any other barrier. One brand has a small perception problem: 15% ... Exploring Market Access Barriers Market Access Impact: NSCLC explores key issues affecting NSCLC drug manufacturers. You’ll learn: How barriers affect market access: ...
August 2016
Global Blood Plasma Market DataPack (2016-2020)
US$ 450.00
The Industry DataPack provides a unique mix of market information, analysis and estimates based on quantitative and qualitative research. The market figures and ... also explores the competitive landscape of the respective market with focus on major players. The DataPack serves as a must read for anyone willing ...
August 2016
63 pages
2016 Italy Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay
US$ 2,000.00
... unique report from VPGMarketResearch provides Italy sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The ... -Clinical Diagnostics Panacea Pharmaceuticals Polartechnics Polymedco PreMD Qiagen Quest Diagnostics Radient Pharmaceuticals Roche Scienion Sequenom Siemens Healthcare Takara Bio Targeted Diagnostics ...
August 2016
125 pages
2016 Japan Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay
US$ 2,400.00
... unique report from VPGMarketResearch provides Japan sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The ... -Clinical Diagnostics Panacea Pharmaceuticals Polartechnics Polymedco PreMD Qiagen Quest Diagnostics Radient Pharmaceuticals Roche Scienion Sequenom Siemens Healthcare Takara Bio Targeted Diagnostics ...
August 2016
129 pages
2016 Spain Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay
US$ 2,360.00
... unique report from VPGMarketResearch provides Spain sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The ... -Clinical Diagnostics Panacea Pharmaceuticals Polartechnics Polymedco PreMD Qiagen Quest Diagnostics Radient Pharmaceuticals Roche Scienion Sequenom Siemens Healthcare Takara Bio Targeted Diagnostics ...
August 2016
128 pages
2016 UK Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay
US$ 2,080.00
... provides UK sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The report also presents strategic ... -Clinical Diagnostics Panacea Pharmaceuticals Polartechnics Polymedco PreMD Qiagen Quest Diagnostics Radient Pharmaceuticals Roche Scienion Sequenom Siemens Healthcare Takara Bio Targeted Diagnostics ...
August 2016
124 pages
2016 US Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay
US$ 3,200.00
... provides US sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The report also presents strategic ... -Clinical Diagnostics Panacea Pharmaceuticals Polartechnics Polymedco PreMD Qiagen Quest Diagnostics Radient Pharmaceuticals Roche Scienion Sequenom Siemens Healthcare Takara Bio Targeted Diagnostics ...
August 2016
136 pages
Italy Nucleic Acid Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 5,360.00
... Testing - Genetic Diseases - Paternity Testing/HLA Typing Review of testing methodologies and instrumentation technologies. Feature comparison of automated and semiautomated analyzers. Sales and market ... instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological ...
August 2016
1117 pages
